166 related articles for article (PubMed ID: 36621213)
1. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
Pedrosa AR; Martins DC; Rizzo M; Silva-Nunes J
J Diabetes Complications; 2023 Feb; 37(2):108391. PubMed ID: 36621213
[TBL] [Abstract][Full Text] [Related]
2. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.
Plowman TJ; Christensen H; Aiges M; Fernandez E; Shah MH; Ramana KV
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791227
[TBL] [Abstract][Full Text] [Related]
3. Investigating the impact of metformin on severity of COVID-19 in patients with Type 2 diabetes mellitus: Focusing on laboratory findings.
Taheri R; Shahrokhi SZ; Amjadi Z; Kazerouni F
Endocrinol Diabetes Metab; 2023 Sep; 6(5):e441. PubMed ID: 37431844
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
Chen X; Guo H; Qiu L; Zhang C; Deng Q; Leng Q
Front Immunol; 2020; 11():2056. PubMed ID: 32973814
[TBL] [Abstract][Full Text] [Related]
5. Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.
Wiernsperger N; Al-Salameh A; Cariou B; Lalau JD
Diabetes Metab; 2022 Jul; 48(4):101359. PubMed ID: 35662580
[TBL] [Abstract][Full Text] [Related]
6. [Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?].
Scheen AJ; Paquot N
Rev Med Liege; 2021 Mar; 76(3):152-155. PubMed ID: 33682382
[TBL] [Abstract][Full Text] [Related]
7. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
Scheen AJ
Diabetes Metab; 2020 Nov; 46(6):423-426. PubMed ID: 32750451
[TBL] [Abstract][Full Text] [Related]
8. A comment on metformin and COVID-19 with regard to "Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy".
Al-Salameh A; Wiernsperger N; Cariou B; Lalau JD
Diabetes Obes Metab; 2022 Sep; 24(9):1888-1893. PubMed ID: 35545864
[No Abstract] [Full Text] [Related]
9. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.
Zahoor I; Li Y; Rattan R; Giri S
Adv Exp Med Biol; 2021; 1352():211-222. PubMed ID: 35132603
[TBL] [Abstract][Full Text] [Related]
11. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
Ghany R; Palacio A; Dawkins E; Chen G; McCarter D; Forbes E; Chung B; Tamariz L
Diabetes Metab Syndr; 2021; 15(2):513-518. PubMed ID: 33662839
[TBL] [Abstract][Full Text] [Related]
12. Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance.
Hashemi P; Pezeshki S
Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):265-270. PubMed ID: 34057870
[TBL] [Abstract][Full Text] [Related]
13. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.
Rasmi Y; di Bari I; Faisal S; Haque M; Aramwit P; da Silva A; Roshani Asl E
Mol Biol Rep; 2024 Feb; 51(1):316. PubMed ID: 38376656
[TBL] [Abstract][Full Text] [Related]
14. Effects of Metformin, Insulin on Hematological Parameters of COVID-19 Patients with Type 2 Diabetes.
Petakh P; Griga V; Mohammed IB; Loshak K; Poliak I; Kamyshnyiy A
Med Arch; 2022 Oct; 76(5):329-332. PubMed ID: 36545453
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.
Samuel SM; Varghese E; Büsselberg D
Trends Microbiol; 2021 Oct; 29(10):894-907. PubMed ID: 33785249
[TBL] [Abstract][Full Text] [Related]
16. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
[TBL] [Abstract][Full Text] [Related]
17. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
[TBL] [Abstract][Full Text] [Related]
18. Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
Gao Y; Liu T; Zhong W; Liu R; Zhou H; Huang W; Zhang W
Clin Transl Sci; 2020 Nov; 13(6):1055-1059. PubMed ID: 32955785
[TBL] [Abstract][Full Text] [Related]
19. Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.
Li J; Wei Q; Li WX; McCowen KC; Xiong W; Liu J; Jiang W; Marin T; Thomas RL; He M; Gongol B; Hepokoski M; Yuan JX; Shyy JY; Xiong N; Malhotra A
Endocr Pract; 2020 Oct; 26(10):1166-1172. PubMed ID: 33471718
[TBL] [Abstract][Full Text] [Related]
20. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
